Xinbo Qiao

627 total citations · 1 hit paper
19 papers, 407 citations indexed

About

Xinbo Qiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xinbo Qiao has authored 19 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Xinbo Qiao's work include Advanced Breast Cancer Therapies (3 papers), RNA modifications and cancer (3 papers) and Breast Cancer Treatment Studies (3 papers). Xinbo Qiao is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), RNA modifications and cancer (3 papers) and Breast Cancer Treatment Studies (3 papers). Xinbo Qiao collaborates with scholars based in China and United States. Xinbo Qiao's co-authors include Lisha Sun, Caigang Liu, Jinqi Xue, Guanglei Chen, Xudong Zhu, Jiawen Bu, Yongliang Yang, Da Li, Tingting Li and Yuanyuan Fang and has published in prestigious journals such as Nature Communications, IEEE Access and Molecular Cancer.

In The Last Decade

Xinbo Qiao

19 papers receiving 403 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetics-targeted drugs: current paradigms and future challenges

2024 94 citations Wanlin Dai, Xinbo Qiao et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinbo Qiao China	12	213	135	80	63	53	19	407
И. Е. Повереннова Russia	6	176 0.8×	166 1.2×	59 0.7×	43 0.7×	69 1.3×	26	473
Kimberly Ng United States	9	261 1.2×	108 0.8×	154 1.9×	70 1.1×	35 0.7×	19	483
Marie D. Ralff United States	11	278 1.3×	130 1.0×	86 1.1×	33 0.5×	49 0.9×	17	406
Cristina Nuevo‐Tapioles Spain	14	452 2.1×	91 0.7×	196 2.5×	63 1.0×	34 0.6×	23	664
Tianjie Pu China	13	203 1.0×	174 1.3×	199 2.5×	96 1.5×	32 0.6×	29	450
Changqie Pan China	14	288 1.4×	159 1.2×	163 2.0×	115 1.8×	20 0.4×	21	535
Maithao Le United States	12	231 1.1×	175 1.3×	46 0.6×	56 0.9×	36 0.7×	22	466
Dingzhang Xiao China	12	273 1.3×	146 1.1×	91 1.1×	36 0.6×	17 0.3×	15	504
Elena Tutunea-Fatan Canada	9	185 0.9×	176 1.3×	73 0.9×	30 0.5×	24 0.5×	15	387
Megan Wu Canada	10	442 2.1×	109 0.8×	73 0.9×	83 1.3×	19 0.4×	12	606

Countries citing papers authored by Xinbo Qiao

Since Specialization

Citations

This map shows the geographic impact of Xinbo Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbo Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbo Qiao more than expected).

Fields of papers citing papers by Xinbo Qiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinbo Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbo Qiao. The network helps show where Xinbo Qiao may publish in the future.

Co-authorship network of co-authors of Xinbo Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Xinbo Qiao. A scholar is included among the top collaborators of Xinbo Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinbo Qiao. Xinbo Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dai, Wanlin, Xinbo Qiao, Yuanyuan Fang, et al.. (2024). Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduction and Targeted Therapy. 9(1). 332–332. 94 indexed citations breakdown →

Bu, Jiawen, Yixiao Zhang, Sijin Wu, et al.. (2023). KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nature Communications. 14(1). 2602–2602. 36 indexed citations

Zhang, Yinan, Yang Bai, Xin Wang, et al.. (2023). Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study. eLife. 12. 2 indexed citations

Chen, Guanglei, Lisha Sun, Xi Gu, et al.. (2023). FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Science China Life Sciences. 66(12). 2805–2817. 11 indexed citations

Qiao, Xinbo, Yixiao Zhang, Zhan Zhang, et al.. (2023). KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes. Asian Journal of Pharmaceutical Sciences. 18(3). 100814–100814. 7 indexed citations

Xing, Fei, Hongli Gao, Guanglei Chen, et al.. (2023). CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Molecular Cancer. 22(1). 6–6. 31 indexed citations

Bu, Jiawen, Yixiao Zhang, Lisha Sun, et al.. (2022). Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer. eLife. 12. 8 indexed citations

Xue, Jinqi, Xudong Zhu, Xinbo Qiao, et al.. (2022). CEMIP as a potential biomarker and therapeutic target for breast cancer patients. International Journal of Medical Sciences. 19(3). 434–445. 13 indexed citations

Sun, Lisha, Yixiao Zhang, Guanglei Chen, et al.. (2022). Targeting SOST using a small-molecule compound retards breast cancer bone metastasis. Molecular Cancer. 21(1). 228–228. 23 indexed citations

10.

Liu, Caigang, Yixiao Zhang, Qi Zhang, et al.. (2022). A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells. Drug Resistance Updates. 66. 100903–100903. 27 indexed citations

11.

Chen, Guanglei, Xinbo Qiao, Hui Chen, et al.. (2022). NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer. Frontiers in Pharmacology. 13. 823140–823140. 16 indexed citations

12.

Qiao, Xinbo, Yixiao Zhang, Lisha Sun, et al.. (2021). Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis. eLife. 10. 24 indexed citations

13.

Zhang, Yixiao, Xudong Zhu, Xinbo Qiao, et al.. (2020). LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer. Journal of Cellular and Molecular Medicine. 24(16). 9125–9134. 19 indexed citations

14.

Zhu, Xudong, Yang Bai, Xi Gu, et al.. (2020). HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients. International Journal of Medical Sciences. 17(17). 2773–2789. 13 indexed citations

15.

Zhang, Yixiao, Xudong Zhu, Xinbo Qiao, et al.. (2020). FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis. International Journal of Medical Sciences. 17(17). 2819–2825. 4 indexed citations

16.

Zhang, Yixiao, et al.. (2020). Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma. International Journal of Medical Sciences. 18(1). 239–244. 4 indexed citations

17.

Zhu, Xudong, Jinqi Xue, Xi Gu, et al.. (2019). Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer. Journal of Cancer. 10(23). 5661–5670. 5 indexed citations

18.

Wang, Liqian, Xiaoyu Cui, Jinqi Xue, et al.. (2019). Breast-Shape Classification and Implant Construction Method for Unilateral Breast Reconstruction. IEEE Access. 7. 157506–157512. 1 indexed citations

19.

Qiao, Xinbo, Xuanyu Hao, Yao Xiao, et al.. (2018). The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients. OncoTargets and Therapy. Volume 11. 4913–4944. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact